A Single Center, Randomized, Double-blind, Placebo-controlled 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain.
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2015
At a glance
- Drugs Etoricoxib (Primary)
- Indications Osteoarthritis
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 May 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov record.